Challenges in the Management of Viral Hepatitis, ESCMID Postgraduate Education Course

14 - 15 October 2016, Cavtat, Croatia

  • ESCMID Study Group for Viral Hepatitis (ESGVH)
  • Trainee Association of ESCMID (TAE)
  • Croatian Society for Infectious Diseases (HDIB)
  • French Society for Infectious Diseases (SPILF)
  • Infectious Diseases and Clinical Microbiology Specialty Society of Turkey (EKMUD)
  • University of Zagreb, School of Medicine
  • WHO Country Office in Croatia

Course Coordinators
  • Joop E. Arends, Utrecht, Netherlands
  • Davorka Dušek, Zagreb, Croatia
  • Hakan Leblebicioglu, Samsun, Turkey
  • Dominique Salmon, Paris, France
  • Adriana Vince, Zagreb, Croatia
Course Objectives
  • Review the epidemiology of HCV and HBV infection from a European and global perspective
  • Describe pathogenesis and natural history of HCV and HBV infection
  • Discuss currently available treatment regimens and explain how to choose appropriate strategies in real life settings
  • Discuss implementation of current treatment guidelines in different resource settings
  • Learn how to manage HCV and HBV infections in special populations (transplant patients, cirrhotics, pregnant women, elderly population, etc.)
  • Review treatment of HDV and HEV infection
Course Venue

Hotel Croatia
Frankopanska 10
20210 Cavtat-Dubrovnik

Phone +385 20 300 300
Fax +385 20 300 310

Target Audience

30 – 50 infectious disease and clinical microbiology specialists and trainees, gastroenterologists, clinicians taking care of patients with viral hepatitis and public health specialists.

Contact Person (Scientific Programme)

Prof Adriana Vince

University Hospital for Infectious Diseases
University of Zagreb, School of Medicine
Mirogojska 8
10000 Zagreb

Phone+ 385 128 262 62
Fax+ 385 146 782 44

Administrative Secretariat

Davorka Dusek
University Hospital for Infectious Diseases
"Dr. Fran Mihaljevic"
Mirogojska 8
10000 Zagreb

Phone+ 385 914 012 552
Fax+ 385 128 262 95

Course Programme


Presentations are availabe in the ESCMID Online Lecture Library.

Friday, 14 October 2016

09:00 Opening remarks. Antoinette Kaic-Rak
09:10 What is new in ESCMID in 2016/2017?  Mario Poljak

Basics of HCV infection

Chairs: Philippe Sogni & Adriana Vince
09:20 The epidemiology of HCV infection from the European and global perspective.
Massimo Puoti

09:00 Natural history of HCV infection – what is the impact of untreated disease?
Mario Mondelli
10:00 Quality of life in patients with chronic hepatitis C. Adriana Vince
10:20 Should we be aiming for prevention, not eradication? Mojca Maticic
10:45 Coffee break

What is new in HCV treatment?
Chairs: Hakan Leblebicioglu & Mojca Maticic
11:00 State of the art of hepatitis C treatment: news from EASL’s and AASLD’s recommendations. Dominique Salmon
11:30 Use of molecular tools to optimize treatment for HCV. Mario Poljak
12:00 How to follow treatment guidelines in different resource settings. Joop E. Arends & Adriana Vince
12:30 How to proceed after HCV cure? Lionel Piroth
13:00 Lunch

How to choose the best treatment for your patient with chronic hepatitis C?
Chair: William Irving
14:30 Managing cirrhotic patients. Resat Ozaras
14:50 Treating patients in peritransplant settings. Tajana Filipec-Kanižaj
15:30 How to manage DAA failure? Andrew Ustianowski
16:00 Coffee break

Treatment of HCV in special populations
Chairs: Resat Ozaras & Nassim Kamar
16:15 Treatment of patients with genotype 3. Andrew Ustianowski
16:35 Treatment of patients with renal failure. Philippe Sogni
16:55 Treatment of elderly patients and management of comorbidities. Vedat Turhan

Saturday, 15 October 2016

Basics of HBV infection
Chairs: Dominique Salmon & Vedat Turhan
09:00 Current HBV epidemiology – far from eradicated disease. Badreddine Kilani
09:30 Natural history of HBV disease – to make sense of the mess. Hakan Leblebicioglu
10:00 HBV vaccine – problems and opportunities. Mojca Maticic
10:30 The importance of molecular diagnostics in HBV treatment. William Irving
11: 00 Coffee break

State of the art of HBV & HDV treatment
Chair: Lionel Piroth
11:15 HBV treatment in the light of current international guidelines. Resat Ozaras
11:45 How to achieve “cure” in HBV from a clinician perspective? Andrew Ustianowski
12:15 HDV disease: diagnosis and treatment. Cihan Yurdaydin
12:45 Lunch
14:00 Round table & case studies
Chairs: Philippe Sogni & Alberto Enrico Maraolo

  • HBV and pregnancy
  • HBV in cirrhotic patients
  • Acute HBV infection

15:00 Coffee break

Treatment of viral hepatitis in special populations

Chairs: Tajana Filipec-Kanižaj & Badreddine Kilani
15:15 HBV reactivation in immunosuppressed patients. Joop E. Arends
15:35 HEV infection in immunocompromised patients. Nassim Kamar
15:55 HDV in cirrhotic patients. Cihan Yurdaydin
16:15 Closing remarks

Faculty Members
  • Joop E. Arends, Utrecht, Netherlands
  • Tajana Filipec-Kanižaj, Zagreb, Croatia
  • William Irving, Nottingham, United Kingdom
  • Antoinette Kaic-Rak, Zagreb, Croatia
  • Nassim Kamar, Toulouse, France
  • Badreddine Kilani, Tunis, Tunisia
  • Hakan Leblebicioglu, Samsun, Turkey
  • Alberto Enrico Maraolo, Bologna, Italy
  • Mojca Maticic, Ljubljana, Slovenia
  • Mario Mondelli, Pavia, Italy
  • Resat Ozaras, Istanbul, Turkey
  • Lionel Piroth, Dijon, France
  • Mario Poljak, Ljubljana, Slovenia
  • Massimo Puoti, Milan, Italy
  • Dominique Salmon, Paris, France
  • Philippe Sogni, Paris, France
  • Vedat Turhan, Istanbul, Turkey
  • Andrew Ustianowski, Manchester, United Kingdom
  • Adriana Vince, Zagreb, Croatia
  • Cihan Yurdaydin, Ankara, Turkey
CME Accreditation

The event was granted 11 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).